These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30515760)

  • 1. Ertapenem - a potent treatment for clinical and quality of life improvement in patients with hidradenitis suppurativa- Reply.
    Lyons AB; Parks-Miller A; Zubair R; Hamzavi IH
    Int J Dermatol; 2019 Apr; 58(4):E88. PubMed ID: 30515760
    [No Abstract]   [Full Text] [Related]  

  • 2. Ertapenem - a potent treatment for clinical and quality of life improvement in patients with hidradenitis suppurativa.
    Braunberger TL; Nartker NT; Nicholson CL; Nahhas AF; Parks-Miller A; Hanna Z; Jayaprakash R; Ramesh MS; Rambhatla PV; Hamzavi IH
    Int J Dermatol; 2018 Sep; 57(9):1088-1093. PubMed ID: 29774531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter to the Editor regarding "Ertapenem - a potent treatment for clinical and quality of life improvement in patients with hidradenitis suppurativa".
    Hegde SG; Ravikumar BC
    Int J Dermatol; 2019 Apr; 58(4):E87-E88. PubMed ID: 30246278
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemoglobin as an indicator of disease activity in severe hidradenitis suppurativa.
    Braunberger TL; Lowes MA; Hamzavi IH
    Int J Dermatol; 2019 Sep; 58(9):1090-1091. PubMed ID: 30094834
    [No Abstract]   [Full Text] [Related]  

  • 5. Interobserver variability of clinical scores in hidradenitis suppurativa is low.
    Sartorius K; Killasli H; Heilborn J; Jemec GB; Lapins J; Emtestam L
    Br J Dermatol; 2010 Jun; 162(6):1261-8. PubMed ID: 20184581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical Benefits Scheme listing of adalimumab for hidradenitis suppurativa: Is hidradenitis suppurativa a life-changing drug or does lifestyle change the drug?
    Vekic DA; Frew JW
    Australas J Dermatol; 2018 Aug; 59(3):e243-e244. PubMed ID: 29285755
    [No Abstract]   [Full Text] [Related]  

  • 7. Achieving Hidradenitis Suppurativa Response Score is Associated with Significant Improvement in Clinical and Patient-reported Outcomes: Post Hoc Analysis of Pooled Data From PIONEER I and II.
    Kimball AB; Tzellos T; Calimlim BM; Teixeira HD; Geng Z; Okun MM
    Acta Derm Venereol; 2018 Nov; 98(10):932-937. PubMed ID: 30085324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.
    Kimball AB; Jemec GB; Yang M; Kageleiry A; Signorovitch JE; Okun MM; Gu Y; Wang K; Mulani P; Sundaram M
    Br J Dermatol; 2014 Dec; 171(6):1434-42. PubMed ID: 25040429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ertapenem for the treatment of Hidradenitis suppurativa: how much do we need it?
    Mendes-Bastos P; Martorell A; Magina S
    Actas Dermosifiliogr (Engl Ed); 2018 Sep; 109(7):582-583. PubMed ID: 29803362
    [No Abstract]   [Full Text] [Related]  

  • 10. Quality-of-Life Measures in Hidradenitis Suppurativa: The Importance of High-Quality Methodology and Standards.
    Frew JW
    J Cutan Med Surg; 2018; 22(3):368. PubMed ID: 29865952
    [No Abstract]   [Full Text] [Related]  

  • 11. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
    Caposiena Caro RD; Cannizzaro MV; Botti E; Di Raimondo C; Di Matteo E; Gaziano R; Bianchi L
    J Am Acad Dermatol; 2019 May; 80(5):1314-1321. PubMed ID: 30502416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Author Response: Quality-of-Life Measures in Hidradenitis Suppurativa: The Importance of High-Quality Methodology and Standards.
    McLellan C; Tan J
    J Cutan Med Surg; 2018; 22(3):369-371. PubMed ID: 29865953
    [No Abstract]   [Full Text] [Related]  

  • 13. Hidradenitis Suppurativa: A Case Study.
    Schulman ML; Pantuso HM
    J Pediatr Health Care; 2015; 29(4):364-70. PubMed ID: 25575404
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients.
    Join-Lambert O; Coignard-Biehler H; Jais JP; Delage M; Guet-Revillet H; Poirée S; Duchatelet S; Jullien V; Hovnanian A; Lortholary O; Nassif X; Nassif A
    J Antimicrob Chemother; 2016 Feb; 71(2):513-20. PubMed ID: 26565016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of Hidradenitis Suppurativa.
    Wortsman X
    Dermatol Clin; 2016 Jan; 34(1):59-68. PubMed ID: 26617359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychophysical aspects of hidradenitis suppurativa.
    Matusiak L; Bieniek A; Szepietowski JC
    Acta Derm Venereol; 2010 May; 90(3):264-8. PubMed ID: 20526543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refining the hidradenitis suppurativa Hurley staging system for mild, moderate and severe disease.
    Ingram JR
    Br J Dermatol; 2019 May; 180(5):991-992. PubMed ID: 31025756
    [No Abstract]   [Full Text] [Related]  

  • 18. Physician severity scores correlate poorly with health-related quality of life in patients with Hidradenitis Suppurativa.
    van Straalen KR; van Trigt I; Prens EP; van der Zee HH
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):e722-e724. PubMed ID: 32348584
    [No Abstract]   [Full Text] [Related]  

  • 19. Intramuscular ertapenem for the treatment of severe cases hidradenitis suppurativa.
    Segura Palacios JM; Soto Moreno A; Valladares Millán I; Rivas Ruiz F; Cuenca Barrales C; Molina Leyva A
    J Dermatolog Treat; 2023 Dec; 34(1):2179368. PubMed ID: 36779676
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of Itch and Pain on Sleep Quality in Patients with Hidradenitis Suppurativa.
    Kaaz K; Szepietowski JC; Matusiak Ł
    Acta Derm Venereol; 2018 Aug; 98(8):757-761. PubMed ID: 29756157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.